Operationalising the "One Health" approach in India: facilitators of and barriers to effective cross-sector convergence for zoonoses prevention and control.

Operationalising the "One Health" approach in India: facilitators of and barriers to effective cross-sector convergence for zoonoses prevention and control.
复制标题

在印度运营“一种健康”方法:有效的人畜共患病预防和控制的有效跨部门融合的障碍。

DOI:
10.1186/s12889-021-11545-7
复制
发表时间:
2021-08-06
期刊:
影响因子:
4.5
通讯作者:
Purse BV
Purse BV
中科院分区:
医学2区
文献类型:
--
作者:
Asaaga FA;Young JC;Oommen MA;Chandarana R;August J;Joshi J;Chanda MM;Vanak AT;Srinivas PN;Hoti SL;Seshadri T;Purse BV

文献摘要

参考文献

被引文献

相似文献

有一个强大的政策推动力,一个健康的跨部门的方法,以解决复杂的挑战,特别是在低/中低收入国家(LMIC)的人畜共患病。然而,事实证明,在印度等低收入国家实施这一方法具有挑战性,部分原因是对如何促进和维持跨部门合作的实际指导和理解相对有限。本研究通过探索印度人类,动物和环境卫生部门之间成功融合的促进因素和障碍来解决这一差距。使用详细的国家政策文件的内容审查和深入的半结构化访谈数据在印度的人畜共患病管理的混合方法进行了研究。共审查了29份政策文件,并与国家和州一级的政策制定者、疾病管理人员和在人畜共患疾病控制的人-动物-环境界面内工作的专家进行了15次关键信息访谈。我们的研究结果表明,人畜共患病的政策能见度有限,尽管全球人畜共患病,特别是那些被国际组织(如CDC,WHO和OIE)确定为大流行潜力的人畜共患病,而不是当地的高负担地方病,在现有的政策议程设置中得到了高度认可。尽管人们普遍承认跨部门合作的重要性,但在跨部门行动的不同阶段(即分享信息、开展共同活动以及合并资源和基础设施),仍有无数因素制约或促进跨部门融合的成功。重要的是,与会者指出,缺乏支持性政策、部门优先事项相互冲突以及机构能力有限是阻碍在人畜共患病控制方面开展有效跨部门合作的主要障碍。与会者建议,作为前进的方向,应利用现有的非正式人际关系和协作平台。我们的研究结果表明,加强现有国家政策框架是利用跨部门能力改善疾病监测和干预措施的第一步。这就需要对“一个健康”办法进行因地制宜的调整,要敏感地考虑到决定和影响跨部门合作安排成果的基本社会政治、体制和文化背景。在线版本包含补充材料,可通过10.1186/s12889-021-11545-7获得。
There is a strong policy impetus for the One Health cross-sectoral approach to address the complex challenge of zoonotic diseases, particularly in low/lower middle income countries (LMICs). Yet the implementation of this approach in LMIC contexts such as India has proven challenging, due partly to the relatively limited practical guidance and understanding on how to foster and sustain cross-sector collaborations. This study addresses this gap by exploring the facilitators of and barriers to successful convergence between the human, animal and environmental health sectors in India. A mixed methods study was conducted using a detailed content review of national policy documents and in-depth semi-structured interview data on zoonotic disease management in India. In total, 29 policy documents were reviewed and 15 key informant interviews were undertaken with national and state level policymakers, disease managers and experts operating within the human-animal-environment interface of zoonotic disease control. Our findings suggest that there is limited policy visibility of zoonotic diseases, although global zoonoses, especially those identified to be of pandemic potential by international organisations (e.g. CDC, WHO and OIE) rather than local, high burden endemic diseases, have high recognition in the existing policy agenda setting. Despite the widespread acknowledgement of the importance of cross-sectoral collaboration, a myriad of factors operated to either constrain or facilitate the success of cross-sectoral convergence at different stages (i.e. information-sharing, undertaking common activities and merging resources and infrastructure) of cross-sectoral action. Importantly, participants identified the lack of supportive policies, conflicting departmental priorities and limited institutional capacities as major barriers that hamper effective cross-sectoral collaboration on zoonotic disease control. Building on existing informal inter-personal relationships and collaboration platforms were suggested by participants as the way forward. Our findings point to the importance of strengthening existing national policy frameworks as a first step for leveraging cross-sectoral capacity for improved disease surveillance and interventions. This requires the contextual adaptation of the One Health approach in a manner that is sensitive to the underlying socio-political, institutional and cultural context that determines and shapes outcomes of cross-sector collaborative arrangements. The online version contains supplementary material available at 10.1186/s12889-021-11545-7.
DOI: 10.1016/j.onehlt.2019.100101
发表时间: 2019-12-01
期刊: ONE HEALTH
影响因子: 5
作者:
Acharya, Krishna Prasad;Karki, Surendra;Kaphle, Krishna
通讯作者: Kaphle, Krishna
DOI: 10.1098/rstb.2016.0172
发表时间: 2017-07-19
期刊: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
影响因子: --
作者:
Bardosh KL;Scoones JC;Grace D;Kalema-Zikusoka G;Jones KE;de Balogh K;Waltner-Toews D;Bett B;Welburn SC;Mumford E;Dzingirai V
通讯作者: Dzingirai V
DOI: 10.3402/iee.v1i0.8293
发表时间: 2011
影响因子: --
作者:
Asokan GV;Asokan V;Tharyan P
通讯作者: Tharyan P
DOI: 10.1371/journal.pntd.0009265
发表时间: 2021-03
影响因子: 3.8
作者:
Asaaga FA;Rahman M;Kalegowda SD;Mathapati J;Savanur I;Srinivas PN;Seshadri T;Narayanswamy D;Kiran SK;Oommen MA;Young JC;Purse BV
通讯作者: Purse BV
DOI: 10.1136/bmjgh-2018-000880
发表时间: 2018-10-01
期刊: BMJ GLOBAL HEALTH
影响因子: 8.1
作者:
Bennett, Sara;Glandon, Douglas;Rasanathan, Kumanan
通讯作者: Rasanathan, Kumanan